Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2012, Article ID 452143, 9 pages
http://dx.doi.org/10.1155/2012/452143
Review Article

Novel Approach to Bile Duct Damage in Primary Biliary Cirrhosis: Participation of Cellular Senescence and Autophagy

Department of Human Pathology, Kanazawa University Graduate School of Medicine, Kanazawa 920-8640, Japan

Received 30 March 2011; Accepted 20 April 2011

Academic Editor: Yoshiyuki Ueno

Copyright © 2012 Motoko Sasaki and Yasuni Nakanuma. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. E. Gershwin, I. R. Mackay, A. Sturgess, and R. L. Coppel, “Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis,” Journal of Immunology, vol. 138, no. 10, pp. 3525–3531, 1987. View at Google Scholar · View at Scopus
  2. M. M. Kaplan, “Medical progress: primary biliary cirrhosis,” New England Journal of Medicine, vol. 335, no. 21, pp. 1570–1580, 1996. View at Publisher · View at Google Scholar
  3. B. Portmann and Y. Nakanuma, “Diseases of the bile ducts,” in Pathology of the Liver, R. MacSween, A. Burt, B. C. Portmann, K. Ishak, P. Scheuer, and P. Anthony, Eds., pp. 435–506, Churchill Livingstone, London, UK, 4th edition, 2001. View at Google Scholar
  4. M. E. Gershwin and I. R. Mackay, “The causes of primary biliary cirrhosis: convenient and inconvenient truths,” Hepatology, vol. 47, no. 2, pp. 737–745, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Sasaki, A. Ansari, and N. Pumford, “Comparative immunoreactivity of anti-trifluoroacetyl (TFA) antibody and anti-lipoic acid antibody in primary biliary cirrhosis: searching for a mimic,” Journal of Autoimmunity, vol. 15, no. 1, pp. 51–60, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Van de Water, M. E. Gershwin, P. Leung, A. Ansari, and R. L. Coppel, “The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase,” Journal of Experimental Medicine, vol. 167, no. 6, pp. 1791–1799, 1988. View at Google Scholar · View at Scopus
  7. P. S. C. Leung, D. T. Chuang, and R. M. Wynn, “Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope,” Hepatology, vol. 22, no. 2, pp. 505–513, 1995. View at Google Scholar · View at Scopus
  8. C. D. Surh, R. Coppel, and M. E. Gershwin, “Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope,” Journal of Immunology, vol. 144, no. 9, pp. 3367–3374, 1990. View at Google Scholar · View at Scopus
  9. S. P. M. Fussey, J. R. Guest, O. F. W. James, M. F. Bassendine, and S. J. Yeaman, “Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 22, pp. 8654–8658, 1988. View at Google Scholar · View at Scopus
  10. H. Kita, Z. X. Lian, and J. Van De Water, “Identification of HLA-A2-restricted CD8 cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells,” Journal of Experimental Medicine, vol. 195, no. 1, pp. 113–123, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Shimoda, J. Van de Water, and A. Ansari, “Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis,” Journal of Clinical Investigation, vol. 102, no. 10, pp. 1831–1840, 1998. View at Google Scholar · View at Scopus
  12. T. Kamihira, S. Shimoda, and K. Harada, “Distinct costimulation dependent and independent autoreactive T-cell clones in primary biliary cirrhosis,” Gastroenterology, vol. 125, no. 5, pp. 1379–1387, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Nakanuma and G. Ohta, “Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis,” Gastroenterology, vol. 76, no. 6, pp. 1326–1332, 1979. View at Google Scholar · View at Scopus
  14. X. Liu, P. Invernizzi, and Y. Lu, “Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis,” Nature Genetics, vol. 42, no. 8, pp. 658–660, 2010. View at Publisher · View at Google Scholar
  15. G. M. Hirschfield, X. Liu, C. Xu et al., “Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants,” New England Journal of Medicine, vol. 360, no. 24, pp. 2544–2555, 2009. View at Publisher · View at Google Scholar
  16. P. Invernizzi, M. Miozzo, and P. M. Battezzati, “Frequency of monosomy X in women with primary biliary cirrhosis,” Lancet, vol. 363, no. 9408, pp. 533–535, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Invernizzi and M. E. Gershwin, “The genetics of human autoimmune disease,” Journal of Autoimmunity, vol. 33, no. 3-4, pp. 290–299, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. E. Gershwin, C. Selmi, and H. J. Worman, “Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients,” Hepatology, vol. 42, no. 5, pp. 1194–1202, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Selmi, D. L. Balkwill, and P. Invernizzi, “Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium,” Hepatology, vol. 38, no. 5, pp. 1250–1257, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. S. A. Long, C. Quan, and J. Van de Water, “Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis,” Journal of Immunology, vol. 167, no. 5, pp. 2956–2963, 2001. View at Google Scholar · View at Scopus
  21. A. Lleo, C. L. Bowlus, and G. X. Yang, “Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis,” Hepatology, vol. 52, no. 3, pp. 987–996, 2010. View at Publisher · View at Google Scholar
  22. A. Lleo, C. Selmi, and P. Invernizzi, “Apotopes and the biliary specificity of primary biliary cirrhosis,” Hepatology, vol. 49, no. 3, pp. 871–879, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Odin, R. C. Huebert, L. Casciola-Rosen, N. F. LaRusso, and A. Rosen, “Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis,” Journal of Clinical Investigation, vol. 108, no. 2, pp. 223–232, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Sasaki, H. Ikeda, H. Haga, T. Manabe, and Y. Nakanuma, “Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss,” Journal of Pathology, vol. 205, no. 4, pp. 451–459, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Sasaki, H. Ikeda, J. Yamaguchi, S. Nakada, and Y. Nakanuma, “Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence,” Hepatology, vol. 48, no. 1, pp. 186–195, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Sasaki, H. Ikeda, and Y. Nakanuma, “Activation of ATM signaling pathway is involved in oxidative stress-induced expression of mito-inhibitory p21 in chronic non-suppurative destructive cholangitis in primary biliary cirrhosis: an immunohistochemical study,” Journal of Autoimmunity, vol. 31, no. 1, pp. 73–78, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Sasaki, H. Ikeda, Y. Sato, and Y. Nakanuma, “Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis,” American Journal of Pathology, vol. 169, no. 3, pp. 831–845, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Sasaki, M. Miyakoshi, Y. Sato, and Y. Nakanuma, “Autophagy mediates the process of cellular senescence characterizing bile duct damages in primary biliary cirrhosis,” Laboratory Investigation, vol. 90, no. 6, pp. 835–843, 2010. View at Publisher · View at Google Scholar
  29. K. Cadwell, K. K. Patel, and N. S. Maloney, “Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine,” Cell, vol. 141, no. 7, pp. 1135–1145, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Saitoh and S. Akira, “Regulation of innate immune responses by autophagy-related proteins,” Journal of Cell Biology, vol. 189, no. 6, pp. 925–935, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. B. Levine, N. Mizushima, and H. W. Virgin, “Autophagy in immunity and inflammation,” Nature, vol. 469, no. 7330, pp. 323–335, 2011. View at Publisher · View at Google Scholar
  32. M. Sasaki, M. Miyakoshi, Y. Sato, and Y. Nakanuma, “Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis,” Journal of Hepatology, vol. 53, no. 2, pp. 318–325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Collado, M. A. Blasco, and M. Serrano, “Cellular senescence in cancer and aging,” Cell, vol. 130, no. 2, pp. 223–233, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. S. H. Sigal, P. Rajvanshi, and G. R. Gorla, “Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events,” American Journal of Physiology, vol. 276, no. 5, pp. G1260–G1272, 1999. View at Google Scholar · View at Scopus
  35. W. Brodsky Ya. and I. V. Uryvaeva, “Cell polyploidy: its relation to tissue growth and function,” International Review of Cytology, vol. 50, pp. 275–332, 1977. View at Google Scholar · View at Scopus
  36. G. P. Dimri, X. Lee, and G. Basile, “A biomarker that identifies senescent human cells in culture and in aging skin in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 20, pp. 9363–9367, 1995. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Braig, S. Lee, and C. Loddenkemper, “Oncogene-induced senescence as an initial barrier in lymphoma development,” Nature, vol. 436, no. 7051, pp. 660–665, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. V. Krizhanovsky, M. Yon, and R. A. Dickins, “Senescence of activated stellate cells limits liver fibrosis,” Cell, vol. 134, no. 4, pp. 657–667, 2008. View at Publisher · View at Google Scholar
  39. M. Hoare, T. Das, and G. Alexander, “Ageing, telomeres, senescence, and liver injury,” Journal of Hepatology, vol. 53, no. 5, pp. 950–961, 2010. View at Publisher · View at Google Scholar
  40. J. G. Lunz, S. Contrucci, and K. Ruppert, “Replicative senescence of biliary epithelial cells precedes bile duct loss in chronic liver allograft rejection: increased expression of p21 as a disease marker and the influence of immunosuppressive drugs,” American Journal of Pathology, vol. 158, no. 4, pp. 1379–1390, 2001. View at Google Scholar · View at Scopus
  41. V. Paradis, N. Youssef, and P. Bedossa, “Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas,” Human Pathology, vol. 32, no. 3, pp. 327–332, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. S. U. Wiemann, A. Satyanarayana, and M. Tsahuridu, “Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis,” FASEB Journal, vol. 16, no. 9, pp. 935–942, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. R. R. Plentz, Y. N. Park, and A. Lechel, “Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesis,” Hepatology, vol. 45, no. 4, pp. 968–976, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. R. R. Plentz, B. Schlegelberger, and P. Flemming, “Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma,” Hepatology, vol. 42, no. 3, pp. 522–526, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. B. Portmann and Y. Nakanuma, “Diseases of the bile ducts,” in Pathology of the Liver, A. Burt, B. C. Portmann, and L. D. Ferrell, Eds., pp. 517–581, Churchill Livingstone, London, UK, 5th edition, 2007. View at Google Scholar
  46. Y. Nakanuma, Y. Zen, and K. Harada, “Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: interobserver agreement,” Pathology International, vol. 60, no. 3, pp. 167–174, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Serrano and M. A. Blasco, “Putting the stress on senescence,” Current Opinion in Cell Biology, vol. 13, no. 6, pp. 748–753, 2001. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Demetris, “Immunopathology of the human biliary tree,” in Biliary and Pancreatic Pancreatic Ductal Epithelia, A. Sirica and D. Longnecker, Eds., pp. 127–180, Marcel Dekker, New York, NY, USA, 1997. View at Google Scholar
  49. M. Sasaki, H. Ikeda, Y. Sato, and Y. Nakanuma, “Proinflammatory cytokine-induced cellular senescence of biliary epithelial cells is mediated via oxidative stress and activation of ATM pathway: a culture study,” Free Radical Research, vol. 42, no. 7, pp. 625–632, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. T. A. Roskams, N. D. Theise, and C. Balabaud, “Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers,” Hepatology, vol. 39, no. 6, pp. 1739–1745, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Sasaki, H. Ikeda, J. Yamaguchi, M. Miyakoshi, Y. Sato, and Y. Nakanuma, “Bile ductular cells undergoing cellular senescence increase in chronic liver diseases along with fibrous progression,” American Journal of Clinical Pathology, vol. 133, no. 2, pp. 212–223, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Chiba, M. Sasaki, S. Kitamura, H. Ikeda, Y. Sato, and Y. Nakanuma, “Participation of bile ductular cells in pathologic progression of nonalcoholic fatty liver disease,” Journal of Clinical Pathology, vol. 64, no. 7, pp. 564–570, 2011. View at Google Scholar
  53. N. Mizushima, “Autophagy: process and function,” Genes and Development, vol. 21, no. 22, pp. 2861–2873, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. X. M. Yin, W. X. Ding, and W. Gao, “Autophagy in the liver,” Hepatology, vol. 47, no. 5, pp. 1773–1785, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. B. Levine and G. Kroemer, “Autophagy in the pathogenesis of disease,” Cell, vol. 132, no. 1, pp. 27–42, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. A. R. J. Young, M. Narita, and M. Ferreira, “Autophagy mediates the mitotic senescence transition,” Genes and Development, vol. 23, no. 7, pp. 798–803, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Kabeya, N. Mizushima, and T. Ueno, “LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing,” EMBO Journal, vol. 19, no. 21, pp. 5720–5728, 2000. View at Google Scholar · View at Scopus
  58. E. White and S. W. Lowe, “Eating to exit: autophagy-enabled senescence revealed,” Genes and Development, vol. 23, no. 7, pp. 784–787, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Campisi and F. D'Adda di Fagagna, “Cellular senescence: when bad things happen to good cells,” Nature Reviews Molecular Cell Biology, vol. 8, no. 9, pp. 729–740, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. J. C. Barrett, S. Hansoul, and D. L. Nicolae, “Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease,” Nature Genetics, vol. 40, no. 8, pp. 955–962, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. V. Menéndez-Benito and J. Neefjes, “Autophagy in MHC class II presentation: sampling from within,” Immunity, vol. 26, no. 1, pp. 1–3, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. H. J. Anders and D. O. Schlondorff, “Innate immune receptors and autophagy: implications for autoimmune kidney injury,” Kidney International, vol. 78, no. 1, pp. 29–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Lleo, P. Invernizzi, and C. Selmi, “Autophagy: highlighting a novel player in the autoimmunity scenario,” Journal of Autoimmunity, vol. 29, no. 2-3, pp. 61–68, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. J. B. Harley, L. A. Criswell, and C. O. Jacob, “Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci,” Nature Genetics, vol. 40, no. 2, pp. 204–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. J. W. Han, H. F. Zheng, and Y. Cui, “Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus,” Nature Genetics, vol. 41, no. 11, pp. 1234–1237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. J. Nedjic, M. Aichinger, J. Emmerich, N. Mizushima, and L. Klein, “Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance,” Nature, vol. 455, no. 7211, pp. 396–400, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. X. Qu, Z. Zou, and Q. Sun, “Autophagy gene-dependent clearance of apoptotic cells during embryonic development,” Cell, vol. 128, no. 5, pp. 931–946, 2007. View at Publisher · View at Google Scholar · View at Scopus
  68. H. K. Lee, L. M. Mattei, and B. E. Steinberg, “In vivo requirement for Atg5 in antigen presentation by dendritic cells,” Immunity, vol. 32, no. 2, pp. 227–239, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. G. Hu and B. J. Barnes, “IRF-5 is a mediator of the death receptor-induced apoptotic signaling pathway,” Journal of Biological Chemistry, vol. 284, no. 5, pp. 2767–2777, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. X. Ouyang, H. Negishi, R. Takeda, Y. Fujita, T. Taniguchi, and K. Honda, “Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation,” Biochemical and Biophysical Research Communications, vol. 354, no. 4, pp. 1045–1051, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Miceli-Richard, E. Comets, P. Loiseau, X. Puechal, E. Hachulla, and X. Mariette, “Association of an IRF5 gene functional polymorphism with Sjogren's syndrome,” Arthritis and Rheumatism, vol. 56, no. 12, pp. 3989–3994, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. D. Feng, R. C. Stone, and M. L. Eloranta, “Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus,” Arthritis and Rheumatism, vol. 62, no. 2, pp. 562–573, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. J. C. Acosta, A. Banito, and M. V. Guijarro, “Chemokine signaling via the CXCR2 receptor reinforces senescence,” Cell, vol. 133, no. 6, pp. 1006–1018, 2008. View at Publisher · View at Google Scholar · View at Scopus
  74. T. Kuilman, C. Michaloglou, and L. C. W. Vredeveld, “Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network,” Cell, vol. 133, no. 6, pp. 1019–1031, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. N. Wajapeyee, R. W. Serra, X. Zhu, M. Mahalingam, and M. R. Green, “Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7,” Cell, vol. 132, no. 3, pp. 363–374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. D. N. Shelton, E. Chang, P. S. Whittier, D. Choi, and W. D. Funk, “Microarray analysis of replicative senescence,” Current Biology, vol. 9, no. 17, pp. 939–945, 1999. View at Publisher · View at Google Scholar · View at Scopus
  77. J.-P. Coppé, C. K. Patil, F. Rodier et al., “Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor,” PLoS Biology, vol. 6, no. 12, article e301, 2008. View at Publisher · View at Google Scholar
  78. D. Alvaro, M. G. Mancino, and S. Glaser, “Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver,” Gastroenterology, vol. 132, no. 1, pp. 415–431, 2007. View at Publisher · View at Google Scholar · View at Scopus
  79. S. Shimoda, K. Harada, and H. Niiro, “Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells,” Hepatology, vol. 47, no. 3, pp. 958–965, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. K. Tsuneyama, K. Harada, and M. Yasoshima, “Monocyte chemotactic protein-1, -2, and -3 are distinctively expressed in portal tracts and granulomata in primary biliary cirrhosis: implications for pathologenesis,” Journal of Pathology, vol. 193, no. 1, pp. 102–109, 2001. View at Publisher · View at Google Scholar · View at Scopus
  81. K. Isse, K. Harada, Y. Zen et al., “Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts,” Hepatology, vol. 41, no. 3, pp. 506–516, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. M. Yasoshima, N. Kono, H. Sugawara, K. Katayanagi, K. Harada, and Y. Nakanuma, “Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study,” Laboratory Investigation, vol. 78, no. 1, pp. 89–100, 1998. View at Google Scholar · View at Scopus